Cubist Systematic Strategies, LLC Infinity Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.7 $8,077 - $23,274	13,691 New	13,691 $16,000
Q1 2022 May 16, 2022	SELL	$0.85 - $2.4 $37,768 - $106,641	-44,434 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.86 - $3.36 $82,647 - $149,298	44,434 New	44,434 $100,000
Q3 2021 Nov 15, 2021	SELL	$1.52 - $3.82 $137,560 - $345,710	-90,500 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.66 - $3.47 $366,415 - $477,992	-137,750 Reduced 60.35%	90,500 $271,000
Q1 2021 May 17, 2021	BUY	$1.98 - $5.36 $451,935 - $1.22 Million	228,250 New	228,250 $737,000
Q2 2019 Aug 14, 2019	SELL	$1.43 - $1.87 $19,026 - $24,880	-13,305 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.18 - $1.91 $15,699 - $25,412	13,305 New	13,305 $25,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.